In vitro biokinetics of chlorpromazine and the influence of different dose metrics on effect concentrations for cytotoxicity in Balb/c 3T3, Caco-2 and HepaRG cell cultures

Toxicology in Vitro

Volumn 27, Issue 3, 2013, Pages 1057-1064

  Broeders, Jessica J W ^a   Blaauboer, Bas J ^a   Hermens, Joop L M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Balb c 3T3 cells; Biokinetics; Caco 2 cells; Cytotoxicity; HepaRG cells

Indexed keywords

CHLORPROMAZINE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL STRAIN 3T3; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EXPOSURE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MOUSE; NONHUMAN;

ANIMALS; ANTIPSYCHOTIC AGENTS; BALB 3T3 CELLS; CACO-2 CELLS; CELL LINE; CHLORPROMAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MICE;

EID: 84874745956     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.01.010     Document Type: Article

References (42)

1. Aninat C., Piton A., Glaise D., Le Charpentier T., Langouët S., Morel F., Guguen-Guillouzo C., Guillouzo A. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab. Dispos. 2006, 34:75-83.
2. Aungst B.J., Nguyen N.H., Bulgarelli J.P., Oates-Lenz K. The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm. Res. 2000, 17:1175-1180.
3. Broeders J.J.W., Blaauboer B.J., Hermens J.L.M. Development of a negligible depletion-solid phase microextraction method to determine the free concentration of chlorpromazine in aqueous samples containing albumin. J. Chromatogr. A 2011, 1218:8529-8535.
4. Broeders J.J.W., Van Eijkeren J.C.H., Blaauboer B.J., Hermens J.L.M. Transport of chlorpromazine in the Caco-2 cell permeability assay: a kinetic study. Chem. Res. Toxicol. 2012, 25:1442-1451.
5. DeBruyn A.M.H., Gobas F.A.P.C. The sorptive capacity of animal protein. Environ. Toxicol. Chem. 2007, 26:1803-1808.
6. EC, 2006. Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No. 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off. J. Eur. Commun. L 369, 30 December 2006, pp. 1-849.
7. Eisenbrand G., Pool-Zobel B., Baker V., Balls M., Blaauboer B.J., Boobis A., Carere A., Kevekordes S., Lhuguenot J.-C., Pieters R., Kleiner J. Methods of in vitro toxicology. Food Chem. Toxicol. 2002, 40:193-236.
8. Endo S., Goss K.-U. Serum albumin binding of structurally diverse neutral organic compounds: data and models. Chem. Res. Toxicol. 2011, 24:2293-2301.
9. Goegan P., Johnson G., Vincent R. Effects of serum protein and colloid on the Alamar Blue assay in cell cultures. Toxicol. In Vitro 1995, 9:257-266.
10. Guillouzo A., Corlu A., Aninat C., Glaise D., Morel F., Guguen-Guillouzo C. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 2007, 168:66-73.
11. Gülden M., Mörchel S., Seibert H. Factors influencing nominal effective concentrations of chemical compounds in vitro: cell concentration. Toxicol. In Vitro 2001, 15:233-243.
12. Gülden M., Mörchel S., Tahan S., Seibert H. Impact of protein binding on the availability and cytotoxic potency of organochlorine pesticides and chlorophenols in vitro. Toxicology 2002, 175:201-213.
13. Gülden M., Mörchel S., Seibert H. Serum albumin binding at cytotoxic concentrations of chemicals as determined with a cell proliferation assay. Toxicol. Lett. 2003, 137:159-168.
14. Gülden M., Seibert H. In vitro-in vivo extrapolation: Estimation of human serum concentrations of chemicals equivalent to cytotoxic concentrations in vitro. Toxicology 2003, 189:211-222.
15. Gülden M., Mörchel S., Seibert H. Comparison of mammalian and fish cell line cytotoxicity: impact of endpoint and exposure duration. Aquat. Toxicol. 2005, 71:229-236.
16. 2 in cell cultures: impact of cell concentration and exposure time. Free Radical Biol. Med. 2010, 49:1298-1305.
17. Heringa M.B., Hermens J.L.M. Measurement of free concentrations using negligible depletion-solid phase microextraction (nd-SPME). Trends Anal. Chem. 2003, 22:575-587.
18. Heringa M.B., Schreurs R.H.M.M., Busser F., Van Der Saag P.T., Van Der Burg B., Hermens J.L.M. Toward more useful in vitro toxicity data with measured free concentrations. Environ. Sci. Technol. 2004, 38:6263-6270.
19. ICCVAM, 2001. Guidance Document on Using in vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity. NIEHS, Research Triangle Park, NC. NIH Publication No. 01-4500.
20. ICCVAM, 2006. ICCVAM-Recommended Test Method Protocol: Balb/c 3T3 NRU Cytotoxicity Test Method. NIEHS, Research Triangle Park, NC. NIH Publication 07-4519.
21. Jossé R., Aninat C., Glaise D., Dumont J., Fessard V., Morel F., Poul J., Guguen-Guillouzo C., Guillouzo A. Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies. Drug Metab. Dispos. 2008, 36:1111-1118.
22. Knöbel M., Busser F.J.M., Rico-Rico A., Kramer N.I., Hermens J.L.M., Hafner C., Tanneberger K., Schirmer K., Scholz S. Predicting adult fish acute lethality with the zebrafish embryo: relevance of test duration, compound properties, and exposure concentration analysis. Environ. Sci. Technol. 2012, 46:9690-9700.
23. Konsoula R., Barile F.A. Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cells. Toxicol. In Vitro 2005, 19:675-684.
24. Kramer N.I., Busser F.J.M., Oosterwijk M.T.T., Schirmer K., Escher B.I., Hermens J.L.M. Development of a partition-controlled dosing system for cell assays. Chem. Res. Toxicol. 2010, 23:1806-1814.
25. Kramer N.I., Krismartina M., Rico-Rico A., Blaauboer B.J., Hermens J.L.M. Quantifying the processes that determine the free concentration of phenanthrene in a basal cytotoxicity assay. Chem. Res. Toxicol. 2012, 25:436-445.
26. Legierse K.C.H.M., Verhaar H.J.M., Vaes W.H.J., de Bruijn J.H.M., Hermens J.L.M. Analysis of the time-dependent acute aquatic toxicity of prganophosphorus pesticides: the critical target occupation model. Environ. Sci. Technol. 1999, 33:917-925.
27. Lilienblum W., DeKant W., Foth H., Gebel T., Hengstler J.G., Kahl R., Kramer P.-M., Schweinfurth H., Wollin K.-M. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Arch. Toxicol. 2008, 82:211-236.
28. Louisse J., de Jong E., van de Sandt J.J.M., Blaauboer B.J., Woutersen R.A., Piersma A.H., Rietjens I.M.C.M., Verwei M. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man. Toxicol. Sci. 2010, 118:470-484.
29. Mingoia R.T., Nabb D.L., Yang C.-H., Han X. Primary culture of rat hepatocytes in 96-well plates: effects of extracellular matrix configuration on cytochrome P450 enzyme activity and inducibility, and its application in in vitro cytotoxicity screening. Toxicol. In Vitro 2007, 21:165-173.
30. Punt A., Schiffelers M.-J.W.A., Horbach G.J., van de Sandt J.J.M., Groothuis G.M.M., Rietjens I.M.C.M., Blaauboer B.J. Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practice. Regul. Toxicol. Pharmacol. 2011, 61:105-114.
31. Reinert K.H., Giddings J.M., Judd L. Effects analysis of time-varying or repeated exposures in aquatic ecological risk assessment of agrochemicals. Environ. Toxicol. Chem. 2002, 21:1977-1992.
32. Sawada G.A., Ho N.F.H., Williams L.R., Barsuhn C.L., Raub T.J. Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning. Pharm. Res. 1994, 11:665-673.
33. Schirmer K. Proposal to improve vertebrate cell cultures to establish them as substitutes for the regulatory testing of chemicals and effluents using fish. Toxicology 2006, 224:163-183.
34. Seibert H., Mörchel S., Gülden M. Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration. Toxicol. In Vitro 2002, 16:289-297.
35. Smith K.E.C., Oostingh G.J., Mayer P. Passive dosing for producing defined and constant exposure of hydrophobic organic compounds during in vitro toxicity tests. Chem. Res. Toxicol. 2010, 23:55-65.
36. Spielmann H., Genschow E., Leibsch M., Halle W. Determination of the starting dose for acute oral toxicity (LD50) testing in the up-and-down procedure (UDP) from cytotoxicity data. ATLA 1999, 27:957-966.
37. Tanneberger K., Rico-Rico A., Kramer N.I., Busser F.J.M., Hermens J.L.M., Schirmer K. Effects of solvents and dosing procedure on chemical toxicity in cell-based in vitro assays. Environ. Sci. Technol. 2010, 44:4775-4781.
38. Udenfriend S., Stein S., Böhlen P., Dairman W., Leimgruber W., Weigele M. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 1972, 178:871-872.
39. Vaes W.H.J., Urrestarazu Ramos E., Verhaar H.J.M., Cramer C.J., Hermens J.L.M. Understanding and estimating membrane/water partition coefficients: approaches to derive quantitative structure property relationships. Chem. Res. Toxicol. 1998, 11:847-854.
40. Van der Jagt, K., Munn, S., Tǿrslǿv, J., de Bruijn, J., 2004. Alternative approaches can reduce the use of test animals under REACH. Addendum to the report " Assessment of additional testing needs under REACH. Effects of (Q)SARs, risk based testing and voluntary industry initiatives" Report EUR 21405. European Commission, Joint Research Centre, Ispra, Italy.
41. Verhaar H.J.M., de Wolf W., Dyer S., Legierse K.C.H.M., Seinen W., Hermens J.L.M. An LC50 vs time model for the aquatic toxicity of reactive and receptor-mediated compounds. Consequences for bioconcentration kinetics and risk assessment. Environ. Sci. Technol. 1999, 33:758-763.
42. Wang K., Shindoh H., Inoue T., Hori I. Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. J. Toxicol. Sci. 2002, 27:229-237.